Avanos Medical (AVNS) Gross Margin (2013 - 2026)

Avanos Medical has disclosed Gross Margin across 14 years of filings, most recently posting 51.7% for Q1 2026.

• In Q1 2026, Gross Margin fell 191.0% year-over-year to 51.7%; the TTM figure through Mar 2026 stood at 50.05% (down 455.0% YoY), while the FY2025 annual figure was 50.47%, down 497.0% from the prior year.
• Gross Margin came in at 51.7% for Q1 2026 at Avanos Medical, up from 47.54% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 59.45% in Q2 2022 to a low of 47.54% in Q4 2025.
• Average Gross Margin over 5 years is 54.68%, with a median of 54.82% recorded in 2023.
• The largest YoY upside for Gross Margin was 1347 bps in 2022 against a maximum downside of 3356 bps in 2022.
• Over 5 years, Gross Margin stood at 56.66% in 2022, then fell by 3 bps to 54.82% in 2023, then retreated by 0 bps to 54.57% in 2024, then retreated by 13 bps to 47.54% in 2025, then rose by 9 bps to 51.7% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 51.7% in Q1 2026, 47.54% in Q4 2025, and 48.37% in Q3 2025.